Delving into the Latest Updates on Chongqing Daxin Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Infectious Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

50S subunit(50S ribosomal subunit)	1

The solubility of moxidectin in different solvents is different.The insoluble and polar two-phase solvent is used for liquid-liquid extraction to reduce the content of A impurity and E+F impurity in moxidectin.The results showed that the best solution of 30% methanol aqueous solution and heptane dissolved in 20∼25°C environment, and the best extraction times is equal volume extraction 3 times.

RSC AdvancesQ3 · CHEMISTRY

pH-responsive chitosan-based flocculant for precise dye flocculation control and the recycling of textile dyeing effluents

Q3 · CHEMISTRY

ArticleOA

Author: Lv, Yin ; Dai, Bin ; Wei, Tingting ; Wu, Liang ; Yu, Feng ; Shi, Yulin ; Chen, Long

Balance between environmental capacity and energy capacity using a pH-responsive chitosan-based flocculant.

100 Deals associated with Chongqing Daxin Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Chongqing Daxin Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data